Metabolic abnormalities: triglyceride and low-density lipoprotein.

Area of Science:

• Biochemistry
• Cardiology
• Metabolic Disorders

Background:

• Metabolic syndrome is characterized by specific lipid profile abnormalities.
• Key features include elevated plasma triglyceride and reduced high-density lipoprotein cholesterol levels.

Purpose of the Study:

• To review the pathophysiology of lipid metabolism in metabolic syndrome.
• To outline the link between these lipoprotein abnormalities and coronary heart disease (CHD) risk.
• To highlight clinical practice applications.

Main Methods:

• Review of existing literature on metabolic syndrome and lipoprotein metabolism.
• Analysis of the relationship between dyslipidemia and CHD risk.
• Discussion of clinical implications.

Main Results:

• Metabolic syndrome involves increased triglycerides and a shift towards small, dense low-density lipoprotein (LDL) particles.
• These dyslipidemias contribute to atherogenesis and elevated coronary heart disease risk.
• The findings have direct relevance for clinical management.

Conclusions:

• Atherogenic dyslipidemia, characterized by high triglycerides and altered LDL, is central to metabolic syndrome.
• Recognizing these lipid abnormalities is essential for assessing and managing cardiovascular risk.
• This knowledge aids in guiding clinical interventions for patients with metabolic syndrome.